Patents Assigned to BLUEROCK THERAPEUTICS LP
  • Publication number: 20250099331
    Abstract: A medical device system including a first container and a second container, the first container including a first container outer body defining a first interior space connected to a first opening of the first container; and a first container-side valve configured to be activated, upon connection of the second container to the first container, from a normally closed position into the first interior space to an activated position, and the second container including a second container outer body defining a second container interior space and a stem fluidly connected to the second container interior space, wherein, upon connection of the second container to the first container, the first container-side valve is configured to be brought into contact with the stem and the stem is configured to activate the first container-side valve from the normally closed position to the activated position.
    Type: Application
    Filed: December 27, 2022
    Publication date: March 27, 2025
    Applicant: BLUEROCK THERAPEUTICS LP
    Inventors: Peter ALDRIDGE, Philippe MARCHAND, Ibrahim DOMIAN, Anna M GALEA, Gregory POLLIERI, Angel Leonardo GUERRERO PALACIO, Brian MAC GIOLLA RI, Jonathan RUBIANTO, Matthew Gardner MAHER, Michael SCOTT
  • Publication number: 20240304008
    Abstract: A method for selecting a final model for detecting cells of interest in image datasets includes dividing a curated image dataset into a training set, a validation set, and a testing set where each image in the curated image dataset has been labeled as positive or negative for a cell of interest. The method trains each model of an ensemble of neural networks using the training and validation sets. Next, each model of the ensemble is tested using the testing set and the predictions of the ensemble are combined. The combined prediction is compared to the label and the method determines whether the combined prediction satisfies a pre-determined level of detection (LOD). If so, the method outputs the ensemble as a final ensemble. If not, the method modifies a hyperparameter of at least one of the models of the ensemble until the combined prediction satisfies the pre-determined LOD.
    Type: Application
    Filed: April 15, 2024
    Publication date: September 12, 2024
    Applicant: BlueRock Therapeutics LP
    Inventors: Dan Charles WILKINSON, Jr., Benjamin Adam BURNETT
  • Publication number: 20240209322
    Abstract: Provided herein are methods of obtaining induced pluripotent stem cells from cells of a hematopoietic lineage.
    Type: Application
    Filed: March 25, 2022
    Publication date: June 27, 2024
    Applicant: BlueRock Therapeutics LP
    Inventors: Peter D. TONGE, Borko TANASIJEVIC
  • Patent number: 11989960
    Abstract: A method for selecting a final model for detecting cells of interest in image datasets includes dividing a curated image dataset into a training set, a validation set, and a testing set where each image in the curated image dataset has been labeled as positive or negative for a cell of interest. The method trains each model of an ensemble of neural networks using the training and validation sets. Next, each model of the ensemble is tested using the testing set and the predictions of the ensemble are combined. The combined prediction is compared to the label and the method determines whether the combined prediction satisfies a pre-determined level of detection (LOD). If so, the method outputs the ensemble as a final ensemble. If not, the method modifies a hyperparameter of at least one of the models of the ensemble until the combined prediction satisfies the pre-determined LOD.
    Type: Grant
    Filed: February 20, 2020
    Date of Patent: May 21, 2024
    Assignee: BlueRock Therapeutics LP
    Inventors: Dan Charles Wilkinson, Jr., Benjamin Adam Burnett
  • Publication number: 20240060047
    Abstract: Provided herein are genetically engineered mammalian (e.g., human) cells that express one or more transgenes at a sustained expression level. Also provided are methods of making and using the cells.
    Type: Application
    Filed: October 9, 2020
    Publication date: February 22, 2024
    Applicant: BlueRock Therapeutics LP
    Inventors: Chew-Li SOH, Mark James TOMISHIMA, Dan Charles WILKINSON, Jr., Conor Brian McAULIFFE
  • Publication number: 20230256177
    Abstract: In some embodiments, a delivery device includes a device actuator and a cannula portion through which a therapeutic substance is ejected. The cannula portion includes an outer shaft, a needle that is configured to move through the outer shaft, and a plunger that is configured to move through the needle, forming a positive displacement arrangement.
    Type: Application
    Filed: April 26, 2023
    Publication date: August 17, 2023
    Applicant: BLUEROCK THERAPEUTICS LP
    Inventors: MATTHEW GARDNER MAHER, ANGEL LEONARDO GUERRERO PALACIO, PHILIPPE MARCHAND
  • Patent number: 11666710
    Abstract: In some embodiments, a delivery device includes a device actuator and a cannula portion through which a therapeutic substance is ejected. The cannula portion includes an outer shaft, a needle that is configured to move through the outer shaft, and a plunger that is configured to move through the needle, forming a positive displacement arrangement.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: June 6, 2023
    Assignee: BLUEROCK THERAPEUTICS LP
    Inventors: Matthew Gardner Maher, Angel Leonardo Guerrero Palacio, Philippe Marchand
  • Publication number: 20220306991
    Abstract: Provided herein are methods of obtaining induced pluripotent stem cells from cells of a hematopoietic lineage.
    Type: Application
    Filed: March 25, 2022
    Publication date: September 29, 2022
    Applicant: BlueRock Therapeutics LP
    Inventors: Peter D. Tonge, Borko Tanasijevic
  • Publication number: 20220228120
    Abstract: Provided herein are enriched populations of ventricular compact cardiomyocytes and enriched populations of mature ventricular or atrial cardiomyocytes, as well as methods of generating the enriched cell populations and methods of using the enriched cell populations in regenerative cardiac cell therapies.
    Type: Application
    Filed: May 4, 2020
    Publication date: July 21, 2022
    Applicants: UNIVERSITY HEALTH NETWORK, BlueRock Therapeutics LP
    Inventors: Gordon M. Keller, Shunsuke Funakoshi, lan Fernandes, Donghe Yang, Dan Charles Wilkinson, Jr.
  • Publication number: 20220172496
    Abstract: A method for selecting a final model for detecting cells of interest in image datasets includes dividing a curated image dataset into a training set, a validation set, and a testing set where each image in the curated image dataset has been labeled as positive or negative for a cell of interest. The method trains each model of an ensemble of neural networks using the training and validation sets. Next, each model of the ensemble is tested using the testing set and the predictions of the ensemble are combined. The combined prediction is compared to the label and the method determines whether the combined prediction satisfies a pre-determined level of detection (LOD). If so, the method outputs the ensemble as a final ensemble. If not, the method modifies a hyperparameter of at least one of the models of the ensemble until the combined prediction satisfies the pre-determined LOD.
    Type: Application
    Filed: February 20, 2020
    Publication date: June 2, 2022
    Applicant: BlueRock Therapeutics LP
    Inventors: Dan Charles WILKINSON, Jr., Benjamin Adam BURNETT
  • Publication number: 20210316081
    Abstract: In some embodiments, a delivery device includes a device actuator and a cannula portion through which a therapeutic substance is ejected. The cannula portion includes an outer shaft, a needle that is configured to move through the outer shaft, and a plunger that is configured to move through the needle, forming a positive displacement arrangement.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 14, 2021
    Applicant: BLUEROCK THERAPEUTICS LP
    Inventors: MATTHEW GARDNER MAHER, ANGEL LEONARDO GUERRERO PALACIO, PHILIPPE MARCHAND